… and neck cancer to show how concurrent chemoradiotherapy is used to treat a cancer where
… The advent of concurrent chemoradiation has significantly contributed to the curability of …

… We sought to identify subgroups of patients with nonmetastatic squamous cell cancer
undergoing concurrent chemotherapy and reirradiation who were more likely to benefit from an …

… chemotherapy in head and neck cancer has evolved since the introduction of chemotherapy
… fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J …

Goals of work Patients with head and neck cancer (HNC) undergoing chemoradiotherapy
are at high risk of malnutrition, which is related to complication rate. The aim of this study was …

… We analyzed the efficacy and toxicity of patients treated with concurrent chemoradiation …
-IV head and neck squamous cell cancer were treated with concurrent chemoradiation using 3D-…

… a growing proportion of squamous cell carcinomas (SCCs) of … III randomized trials, concurrent
chemoradiotherapy (CRT) … benefit of adding chemotherapy (CT) to radiotherapy (RT) of 6.5…

… Concurrent chemoradiotherapy (CRT) has been shown to be superior to radiotherapy (RT)
alone in several clinical therapeutic settings for head and neck cancer (HNC). In …

… The concurrent chemotherapy regimen was determined … cell carcinoma (HNSCC) are
treated with definitive radiotherapy … shown superiority of concurrent chemoradiotherapy (chemoRT) …

… features of tumor heterogeneity have been associated with OS in patients with head and
neck cancers, esophageal cancer, colorectal cancer, and non-small cell lung cancer (NSCLC) …

… benefit over radiotherapy alone in non‐nasopharyngeal SCCHN as seen in nasopharyngeal
and uterine cervical cancers treated with weekly cisplatin‐based chemoradiation ; and (f) …